Another UK COVID-19 vaccine volunteer has been reported as experiencing brain damage during the trials of the AstraZeneca’s experimental vaccine, according to a source the internal papers reveal that both volunteers had suffered from the same serious neurological disorder.
Details of the trial were recently published after the company received criticism over the lack of transparency that is surrounding the testing of the experimental vaccine against the virus that causes COVID-19.
The first participant to fall ill after receiving a single dose of the experimental vaccine in July was part of the British trials. This female volunteer has been diagnosed with transverse myelitis which is a rare inflammatory disease affecting the spinal cord, causing weakness, sensory alterations, and autonomic nervous system dysfunction. Later on, a spokesperson for the company said that the volunteer had undiagnosed multiple sclerosis and the trials resumed.